Sagun Parakh

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

Myung‐Ju Ahn, Kentaro Tanaka, Luis Paz‐Ares et al. · Journal of Clinical Oncology · 2024 · 182 citations · Full text

Medicine, Oncology, Pharmacology +9

Release Studies on Niosomes Containing Fatty Alcohols as Bilayer Stabilizers Instead of Cholesterol

Gopi N. Devaraj, Sagun Parakh, Ravi Devraj et al. · Journal of Colloid and Interface Science · 2002 · 175 citations

Life Sciences, Biochemistry, Biophysics +16

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

James Chih‐Hsin Yang, Dae Ho Lee, Jong‐Seok Lee et al. · Journal of Clinical Oncology · 2024 · 142 citations · Full text

Medicine, Oncology, Pharmacology +14

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy

Samantha Bowyer, Prashanth Prithviraj, Paul Lorigan et al. · British Journal of Cancer · 2016 · 129 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases

Sagun Parakh, John Park, Shehara Mendis et al. · British Journal of Cancer · 2017 · 101 citations · Full text

Medicine, Clinical Sciences, Oncology +17